Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT03123978 · COMPLETED

Trial details

NCT number: NCT03123978
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Carcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2017-01-09
Primary completion: 2022-01-14
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.